Skip to content
sellWeak cluster of 210b5-1 plan

Zurit Levine sold $19k of CGEN

SVP, Business Development at COMPUGEN LTD. 7,875 shares at an average of $2.38, traded Apr 7, 2026, filed Apr 9, 2026.

Warning score
0
Value
$19k
7,875 shares
Holdings after
29,375
-25% from before
From 52-week low
+97%
low $1.18, close $2.32
From 52-week high
-2%
high $2.36, as of Apr 7, 2026

Score components

  • Role
    Officer
    +15
  • Trade size
    $19k at market
    0
  • Share of holdings sold
    Sold 25% of holdings
    +5
  • Cluster
    2 insiders selling within 14 days
    +8
  • Exercise and sell
    Shares came from an option exercise in the same filing
    -15
  • 10b5-1 plan
    Pre-scheduled under a 10b5-1 plan
    -20

What happened after comparable sells

Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.

This signal so far: 1m +16.9%, 3m -0.4%, 6m -14.5%.

Price around the trade, and since

From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.

CGENOct 13, 2026 · close 1.98
Since filing Apr 9, 2026: -20.2%SPY +15.0% · excess -35.2%

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™

Rows in this filing

Every transaction in Form 4 0001178913-26-002036, as filed. Open on EDGAR

DateTransactionSharesPriceValueHoldings afterFiled
Apr 7, 2026MOption exercise
Ordinary Shares10b5-1
+2,500$0.83$2,07331,875Apr 9, 2026
Apr 7, 2026SOpen-market sale
Ordinary Shares10b5-1
-2,500$2.30$5,75029,375Apr 9, 2026
Apr 8, 2026MOption exercise
Ordinary Shares10b5-1
+4,375$0.83$3,62833,750Apr 9, 2026
Apr 8, 2026MOption exercise
Ordinary Shares10b5-1
+1,000$1.15$1,15034,750Apr 9, 2026
Apr 8, 2026SOpen-market sale
Ordinary Shares10b5-1
-5,375$2.42$13k29,375Apr 9, 2026
Apr 7, 2026MOption exercise
Share Option (right to buy)derivative10b5-1
-2,500$0.00$011,125Apr 9, 2026
Apr 8, 2026MOption exercise
Share Option (right to buy)derivative10b5-1
-4,375$0.00$06,750Apr 9, 2026
Apr 8, 2026MOption exercise
Share Option (right to buy)derivative10b5-1
-1,000$0.00$058,000Apr 9, 2026

Related signals

Other insiders at COMPUGEN LTD and this insider’s other filings.

ScoreCompanyInsiderValueHoldingsFiled
0Weak
CGENsell10b5-1
COMPUGEN LTD
Zurit Levine
SVP, Business Development
$4,688
1,875 shares
-6%
8Weak
CGENsell 210b5-1
COMPUGEN LTD
Eran Ophir
President and CEO
$16k
5,000 shares
-31%
0Weak
CGENsell 210b5-1
COMPUGEN LTD
Zurit Levine
SVP, Business Development
$6,400
2,000 shares
-6%
0Weak
CGENsell 210b5-1
COMPUGEN LTD
Zurit Levine
SVP, Business Development
$5,600
2,000 shares
-6%
8Weak
CGENsell 210b5-1
COMPUGEN LTD
Eran Ophir
President and CEO
$15k
5,000 shares
-31%
0Weak
CGENsell 210b5-1
COMPUGEN LTD
Zurit Levine
SVP, Business Development
$8,013
3,125 shares
-10%
0Weak
CGENsell 210b5-1
COMPUGEN LTD
Zurit Levine
SVP, Business Development
$8,013
3,125 shares
-10%
8Weak
CGENsell 210b5-1
COMPUGEN LTD
Eran Ophir
President and CEO
$12k
5,625 shares
-33%
0Weak
CGENsell 210b5-1
COMPUGEN LTD
Zurit Levine
SVP, Business Development
$7,700
3,500 shares
-11%
0Weak
CGENsell 210b5-1
COMPUGEN LTD
Zurit Levine
SVP, Business Development
$24k
11,875 shares
-29%

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Zurit Levine sold $19k of CGEN | InsiderTell